Teza Capital Management LLC Edwards Lifesciences Corp Transaction History

Teza Capital Management LLC

$809 Million
Q2 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $308,802 - $406,798	-4,257 Reduced 22.58%	14,596 $1.39 Million
Q4 2023 Feb 14, 2024	SELL	$61.71 - $77.76 $5.09 Million - $6.42 Million	-82,553 Reduced 81.41%	18,853 $1.44 Million
Q3 2023 Feb 22, 2024	BUY	$69.28 - $93.38 $3.74 Million - $5.04 Million	53,999 Added 1829.23%	56,951 $3.95 Million
Q3 2023 Nov 14, 2023	BUY	$69.28 - $93.38 $6.44 Million - $8.68 Million	93,006 Added 1107.21%	101,406 $7.03 Million
Q2 2023 Feb 22, 2024	SELL	$81.41 - $94.33 $869,947 - $1.01 Million	-10,686 Reduced 78.35%	2,952 $278,000
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $1.34 Million - $1.55 Million	-16,429 Reduced 66.17%	8,400 $792,000
Q1 2023 Feb 22, 2024	SELL	$74.26 - $84.51 $387,265 - $440,719	-5,215 Reduced 27.66%	13,638 $1.13 Million
Q1 2023 May 15, 2023	BUY	$74.26 - $84.51 $749,728 - $853,212	10,096 Added 68.53%	24,829 $2.05 Million
Q4 2022 Feb 14, 2023	BUY	$68.3 - $87.44 $1.01 Million - $1.29 Million	14,733 New	14,733 $1.1 Million
Q2 2022 Aug 15, 2022	SELL	$86.5 - $128.27 $415,200 - $615,696	-4,800 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$101.96 - $128.34 $49,450 - $62,244	-485 Reduced 9.18%	4,800 $565,000
Q4 2021 Feb 14, 2022	SELL	$106.37 - $130.68 $162,320 - $199,417	-1,526 Reduced 22.4%	5,285 $685,000
Q3 2021 Nov 10, 2021	SELL	$102.91 - $122.75 $85,209 - $101,637	-828 Reduced 10.84%	6,811 $771,000
Q2 2021 Aug 06, 2021	SELL	$83.84 - $104.76 $108,908 - $136,083	-1,299 Reduced 14.53%	7,639 $791,000
Q1 2021 May 13, 2021	BUY	$78.68 - $90.67 $703,241 - $810,408	8,938 New	8,938 $748,000
Q1 2020 May 11, 2020	SELL	$52.41 - $81.0 $156,810 - $242,352	-2,992 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$71.7 - $82.09 $214,526 - $245,613	2,992 New	2,992 $698,000
Q3 2019 Nov 12, 2019	SELL	$61.55 - $75.43 $121,438 - $148,823	-1,973 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$55.74 - $64.41 $36,844 - $42,575	661 Added 50.38%	1,973 $364,000
Q1 2019 May 13, 2019	BUY	$47.89 - $64.05 $62,831 - $84,033	1,312 New	1,312 $251,000
Q3 2018 Nov 14, 2018	SELL	$45.7 - $58.03 $416,509 - $528,885	-9,114 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $386,889 - $467,548	9,114 New	9,114 $1.33 Million

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Teza Capital Management LLC with notifications on news.

Account